ASX:ANR

Anatara Lifesciences Stock Forecast, Price & News

Add

Compare

Today's Range N/A

50-Day Range N/A

52-Week Range N/A

Volume3,950 shs

Average VolumeN/A

Market CapitalizationN/A

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Receive ANR News and Ratings via Email

Sign-up to receive the latest news and ratings for Anatara Lifesciences and its competitors with MarketBeat's FREE daily newsletter.

About Anatara Lifesciences

Anatara Lifesciences Limited engages in the research and development of non-antibiotic oral solutions for gastrointestinal diseases in animals and humans in Australia. Its lead product candidate includes Detach, a non-antibiotic therapy that prevents and treats diarrhea disease in piglets. The company is also developing bromelain formulations for gastrointestinal health in humans, as well as for piglets and poultry. Anatara Lifesciences Limited was incorporated in 2010 and is based in Carlton, Australia.

Anatara Lifesciences Ltd.
June 17, 2021 | barrons.com

Anatara Lifesciences Ltd (ANR.AX) Progressing Towards First Human Clinical Studies
May 31, 2021 | sg.finance.yahoo.com

Anatara Lifesciences Ltd (ANR.AX) Q3 FY21 Activities Report
April 27, 2021 | au.finance.yahoo.com

Anatara Lifesciences Ltd (ANR.AX) Ethics Approve Adult Psychological Functioning Trial start
April 20, 2021 | au.finance.yahoo.com

Anatara Lifesciences Ltd (ANR.AX) Announces Australian Patent Grant for Detach
April 16, 2021 | au.finance.yahoo.com

Why the Anatara (ASX:ANR) share price is rocketing 19% today
April 16, 2021 | msn.com

OG Anunoby, Montrezl Harrell ejected after Raptors-Lakers scuffle
April 8, 2021 | uk.finance.yahoo.com

Samsung Profit Surges 44% as Mobile Sales Cushion Fab Loss
April 8, 2021 | uk.finance.yahoo.com

Australia says EU asked it to withdraw vaccine export permit applications
April 8, 2021 | au.finance.yahoo.com

Anatara Lifesciences Ltd (ANR.AX) Market Update
April 7, 2021 | au.finance.yahoo.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange ASX
Industry Biotechnology
Sub-IndustryN/A
SectorMedical
Current SymbolASX:ANR
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.anataralifesciences.com
Phone61 7 3394 8202
EmployeesN/A
Year FoundedN/A

Sales & Book Value

Annual Sales$268,259.00
Price / Sales0.00
Cash FlowN/A
Price / Cash Flow2.33
Book ValueA$0.07 per share
Price / BookN/A

Profitability

Debt

Price-To-Earnings

Miscellaneous

Outstanding SharesN/A
Market CapN/A
Next Earnings DateN/A
OptionableNot Optionable

MarketRank^™

Overall MarketRank^™

0.48 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Anatara Lifesciences.

2.4 Community Rank

Outperform Votes
Anatara Lifesciences has received 13 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Anatara Lifesciences has received 14 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Anatara Lifesciences has received 51.85% “underperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Anatara Lifesciences and other stocks. Vote “Outperform” if you believe ANR will outperform the S&P 500 over the long term. Vote “Underperform” if you believe ANR will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Anatara Lifesciences does not currently pay a dividend.
Dividend Growth
Anatara Lifesciences does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Anatara Lifesciences insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

Anatara Lifesciences (ASX:ANR) Frequently Asked Questions

What stocks does MarketBeat like better than Anatara Lifesciences?

Wall Street analysts have given Anatara Lifesciences a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Anatara Lifesciences wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Anatara Lifesciences' next earnings date?

Anatara Lifesciences is scheduled to release its next quarterly earnings announcement on Monday, August 23rd 2021.
View our earnings forecast for Anatara Lifesciences.

Who are Anatara Lifesciences' key executives?

Anatara Lifesciences' management team includes the following people:

Mr. Steven Lydeamore CPA, M.B.A., MBA, CPA, Chief Exec. Officer
Dr. Michael L. West, Chief Operating Officer (Age 57, Pay $296.83k)
Jane Lowe, Managing Director of IR Department
Dr. Stephen Denaro AGIA, BCom, GradDipApp CG, CA, MAICD, Company Sec.
Ms. Hayley van der Meer B Biomed Sc, Grad Dip Marketing Management, Commercial Mang.

Who are some of Anatara Lifesciences' key competitors?

Some companies that are related to Anatara Lifesciences include (CHV) (CHV), (DDXS) (DDXS), (PREV) (PREV), (TNGN) (TNGN), 45525 (CUR.TO) (CUR), Abattis Bioceuticals (ATTBF), Abzena (ABZA), Acrux (ACR), Actinogen Medical (ACW), AdAlta (1AD), Admedus (AHZ), Algernon Pharmaceuticals (AGNPF), Almirall (LBTSF), Amarantus BioScience (AMBS) and Amplia Therapeutics (ATX).
View all of ANR's competitors.

What other stocks do shareholders of Anatara Lifesciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Anatara Lifesciences investors own include Woodside Petroleum (WPL), Temple & Webster Group (TPW), Brompton Oil Split (OSP), Eagle Materials (EXP), BHP Group (BHP) and Ameriprise Financial (AMP).

What is Anatara Lifesciences' stock symbol?

Anatara Lifesciences trades on the ASX under the ticker symbol "ANR."

How much money does Anatara Lifesciences make?

Anatara Lifesciences has a market capitalization of $0.00 and generates $268,259.00 in revenue each year.

What is Anatara Lifesciences' official website?

The official website for Anatara Lifesciences is www.anataralifesciences.com.

How can I contact Anatara Lifesciences?

The company can be reached via phone at 61 7 3394 8202.

This page was last updated on 7/27/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.